Alkermes PLC $45.03

down 0.00


16/4/2014 08:10 PM  |  NASDAQ : ALKS  
Industries : Drugs / Drug Delivery & Accessories
Get Trend Analysis Icon Get ALKS Trend Analysis - it has outperformed the S&P 500 by 58%

Partner Headlines

  1. Alkermes' drug passes trial

    IBD
  2. Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

    Benzinga
  3. Stocks Rise, Led By Tech Stocks, But Volume Fades

    IBD
  4. Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength

    Benzinga
  5. Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast

    Benzinga
  6. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD
  7. Benzinga's Volume Movers

    Benzinga
  8. Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit Outlook

    Benzinga
  9. Morning Market Movers

    Benzinga
  10. Alkermes Announces Positive Topline Results From Pivotal Phase 3 Study ...

    Benzinga
  11. Benzinga's Top Initiations

    Benzinga
  12. Nasdaq Back Above Water; Green Plains Jumps

    IBD
  13. LifeLock, YY Among 5 Stocks With Top Fundamentals

    IBD
  14. Stocks Fall In Higher Volume; Yandex, Twitter Drop

    IBD
  15. Stocks Weaken After Fed Minutes; Thor Rallies

    IBD
  16. Stocks End Short Week With Big Losses

    IBD
  17. Alkermes Announces Advances in Late-Stage CNS Pipeline

    Benzinga
  18. Alkermes Receives Notice of Allowance of US Patent for Novel Fumarate Prodrug ...

    Benzinga
  19. Ireland Home To Several Fast Growing Health Care Names

    IBD
  20. Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 at 52nd Annual ...

    Benzinga
  21. UPDATE: Citigroup Raises PT on Alkermes on Multiple Value Opportunities

    Benzinga
  22. Alkermes, FDA Agree on Deal for Elements of ALKS 5461 Development Program

    Benzinga
  23. Top 4 Stocks In The Drug Delivery Industry With The Highest Cash

    Benzinga
  24. Acceleron Pharma IPO Pops; Fate Therapeutics On Deck

    IBD
  25. Google, LKQ, Tesla: Stocks A Marsico Manager Likes

    IBD
  26. Stocks End Mixed In Light Trade; Green Mountain Spurts Ahead

    IBD
  27. Stocks Down Modestly; Alkermes Ramps Up

    IBD
  28. Alkermes

    IBD
  29. Stocks Up, Google At High; Dow Takes Out 14,000

    IBD
  30. Regeneron, Other Biomed Stocks Rebound On New Drugs

    IBD
  31. Alkermes

    IBD
  32. Stocks Slip As Fed Stands Pat; SodaStream Trims Gain

    IBD
  33. Alkermes Trades Tightly, Holds In Buying Range

    IBD
  34. UPDATE: Credit Suisse Initiates Alkermes at Neutral; Looking For Better ...

    Benzinga
  35. Celgene Leads 6 Medical Stocks With Bolting RS Lines

    IBD
  36. Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates ...

    Benzinga
  37. Stocks Hold Modest Gains; MI Homes Hits Multiyear High

    IBD
  38. Alkermes In Buy Area After Breakout In Strong Volume

    IBD
  39. Stocks Pare Early Losses, End With Modest Declines

    IBD
  40. Alkermes Announces Notice of Allowance of USPTO Application for Aripiprazole ...

    Benzinga
  41. Alkermes Announces Positive Results from Phase 1 Study of ALKS 3831

    Benzinga
  42. Biotech Alkermes Sketches Imperfect Cup With Handle

    IBD
  43. Alkermes' Acquisition Proves To Be Game-Changer

    IBD
  44. Alkermes' Corporate Presentation to be Webcast at Two Upcoming Conferences

    Benzinga
  45. Dow Leads Market Higher As Volume Swells

    IBD
  46. Stocks Add To Gains; DaVita HealthCare Jumps

    IBD
  47. Alkermes Flies As Q2 Results, Guidance Beat Estimates

    IBD
  48. Alkermes' Breakout Falls Victim To Market Correction

    IBD
  49. Stocks Tumble On Disappointing Earnings Reports

    IBD
  50. Why Cisco, Google And Apple All Became Big Winners

    IBD
Trading Center